These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6726431)

  • 1. The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro.
    Gibson RE; Weckstein DJ; Jagoda EM; Rzeszotarski WJ; Reba RC; Eckelman WC
    J Nucl Med; 1984 Feb; 25(2):214-22. PubMed ID: 6726431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB.
    Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Knapp FF
    Recept Signal Transduct; 1997; 7(1):45-54. PubMed ID: 9285530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors.
    Gibson RE; Rzeszotarski WJ; Jagoda EM; Francis BE; Reba RC; Eckelman WC
    Life Sci; 1984 Jun; 34(23):2287-96. PubMed ID: 6727565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer.
    Eckelman WC; Eng R; Rzeszotarski WJ; Gibson RE; Francis B; Reba RC
    J Nucl Med; 1985 Jun; 26(6):637-42. PubMed ID: 3998853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.
    Gibson RE; Eckelman WC; Vieras F; Reba RC
    J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies.
    Sawada Y; Hiraga S; Francis B; Patlak C; Pettigrew K; Ito K; Owens E; Gibson R; Reba R; Eckelman W
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):781-807. PubMed ID: 2134838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNB.
    Gitler MS; Boulay SF; Sood VK; McPherson DW; Knap FF; Zeeberg BR; Reba RC
    Brain Res; 1995 Jul; 687(1-2):71-8. PubMed ID: 7583315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors.
    Gibson RE; Rzeszotarski WJ; Eckelman WC; Jagoda EM; Weckstein DJ; Reba RC
    Biochem Pharmacol; 1983 Jun; 32(12):1851-6. PubMed ID: 6882462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal function impairment in rabies-infected rat brain.
    Tsiang H
    J Gen Virol; 1982 Aug; 61 (Pt 2)():277-81. PubMed ID: 7119753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B; Jaszczak R; Coleman E; Storni A; Greer K; Petry N; Lischko M; Flanagan S
    J Comput Assist Tomogr; 1982 Jun; 6(3):536-43. PubMed ID: 6980235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and properties of (R)-(-)-1-azabicyclo[2.2.2]oct-3-yl- (R)-(+)-alpha-hydroxy-alpha-(4-[125I]iodophenyl)-alpha-phenyl acetate and (R)-(-)-1-azabicyclo[2.2.2]oct-3-yl-(S)-(-)-alpha-hydroxy-alpha- (4-[125I]iodophenyl)-alpha-phenyl acetate as potential radiopharmaceuticals.
    Cohen VI; Rzeszotarski WJ; Gibson RE; Fan LH; Reba RC
    J Pharm Sci; 1989 Oct; 78(10):833-6. PubMed ID: 2600789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro characteristics of the N-methyl derivative of [125I]3-quinuclidinyl 4-iodobenzilate.
    Gibson RE; Coenen HH; Jagoda E; Reba RC; Eckelman WC
    Int J Nucl Med Biol; 1984; 11(2):167-9. PubMed ID: 6480260
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
    McPherson DW; DeHaven-Hudkins DL; Callahan AP; Knapp FF
    J Med Chem; 1993 Apr; 36(7):848-54. PubMed ID: 8464039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
    Mittal CK
    Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo autoradiographic and dissection evaluation of isomers of 125I-labeled 1-azabicyclo[2.2.2] oct-3-yl-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IQNP).
    Rayeq MR; Boulay SF; Sood VK; McPherson DW; Knapp FF; Zeeberg BR
    Recept Signal Transduct; 1996; 6(1):13-34. PubMed ID: 8933619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
    Marks MJ; Collins AC
    Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phencyclidine and two monohydroxy metabolites on 3H QNB binding in vivo in rats.
    Boggan WO; Stringer AJ; Faught K; Middaugh LD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):847-9. PubMed ID: 3602041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.